| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/08/2007 | CA2427764C Transdermal drug delivery system with improved water absorbability and adhesion properties |
| 05/08/2007 | CA2391926C Composition containing xylitol and fiber |
| 05/08/2007 | CA2373990C Pyrrolotriazine inhibitors of kinases |
| 05/08/2007 | CA2366995C Compounds derived from benzoic acid esters, composition containing said compounds and use thereof |
| 05/08/2007 | CA2342950C New process for preparing 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]-thia zepine and application in the synthesis of tianeptine |
| 05/08/2007 | CA2342435C A pharmaceutical composition for inhibiting non-intentional behavior and use of a running neuron inhibitory substance for producing the pharmaceutical composition |
| 05/08/2007 | CA2339528C Hexahydropyrazolo[4,3-c]pyridine metabolites |
| 05/08/2007 | CA2331870C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 05/08/2007 | CA2328314C Long chain alcohols admixed in sterol compounds |
| 05/08/2007 | CA2325741C Urea derivatives having tnf- .alpha. production inhibitory effects |
| 05/08/2007 | CA2317690C Predicting survival of patients with squamous cell carcinoma |
| 05/08/2007 | CA2310593C Metalloproteinase inhibitors |
| 05/08/2007 | CA2306837C Treatment of female sexual dysfunction |
| 05/08/2007 | CA2293612C Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |
| 05/08/2007 | CA2290421C Multicyclic erythromycin derivatives |
| 05/08/2007 | CA2280309C Use of adrafinil to treat behavioral problems in aged canines |
| 05/08/2007 | CA2276098C Tricyclic benzo[e]isoindoles and benzo[h]isoquinolines |
| 05/08/2007 | CA2275479C Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/08/2007 | CA2267498C Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 05/08/2007 | CA2262267C Anti-migraine pharmaceutical compositions and process of using |
| 05/08/2007 | CA2258177C 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function |
| 05/08/2007 | CA2253338C 6-o-substituted erythromycins and method for making them |
| 05/08/2007 | CA2228492C Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
| 05/08/2007 | CA2215605C Osmotically controlled fermentation process for the preparation of acarbose |
| 05/08/2007 | CA2207120C Use of theophylline derivatives for the treatment and prophylaxis of states of shock, novel xanthine compounds and processes for their preparation |
| 05/08/2007 | CA2185015C Novel silyl compounds and their use |
| 05/08/2007 | CA2182878C Novel cytotoxic macrolides and methods of use |
| 05/08/2007 | CA2176671C A material for elimination or detoxification of super antigens |
| 05/08/2007 | CA2118564C Erythromycin derivatives, process for the preparation thereof and use thereof as medicaments |
| 05/08/2007 | CA2102918C Genetic vaccine for immunodeficiency viruses |
| 05/03/2007 | WO2007051133A2 Substituted thiazoles and their use |
| 05/03/2007 | WO2007051119A1 Methods and compositions of parp inhibitors as potentiators in cancer therapy |
| 05/03/2007 | WO2007051095A1 Salts of modulators of ppar and methods of treating metabolic disorders |
| 05/03/2007 | WO2007051065A2 Compositions and treatments for inhibiting kinase and/or hmg-coa reductase |
| 05/03/2007 | WO2007051062A2 Substituted dihydropyridines and methods of use |
| 05/03/2007 | WO2007050892A2 Camptothecin derivatives and improved synthetic methods |
| 05/03/2007 | WO2007050795A2 Transglutaminase inhibitors and methods of use thereof |
| 05/03/2007 | WO2007050784A2 Fixed ratio drug combination treatments for solid tumors |
| 05/03/2007 | WO2007050783A2 Fasudil in combination therapies for the treatment of pulmonary arterial hypertension |
| 05/03/2007 | WO2007050732A1 INDAZOLE DERIVATIVES THAT INHIBIT TRPVl RECEPTOR |
| 05/03/2007 | WO2007050726A2 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists |
| 05/03/2007 | WO2007050723A1 Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists |
| 05/03/2007 | WO2007050721A2 Heterocyclic aspartyl protease inhibitors |
| 05/03/2007 | WO2007050720A1 Loteprednol etabonate against vascular dysfunction in the eye |
| 05/03/2007 | WO2007050719A1 8-[bis-(2-chloro-phenyl)-methyl]-3-phenyl-8-aza-bicyclo [3.2.1] octane-3-carboxylic acid amide as ligand for the nociceptin receptor orl-1 |
| 05/03/2007 | WO2007050697A2 Compositions and methods for the administration psychotropic drugs which modulate body weight |
| 05/03/2007 | WO2007050673A2 Cyclin dependent kinase inhibitors |
| 05/03/2007 | WO2007050668A1 Analogs of alpha galactosylceramide and uses thereof |
| 05/03/2007 | WO2007050655A2 Combination of histone deacetylase inhibitors and radiation |
| 05/03/2007 | WO2007050615A1 Novel compounds and their use related to compositions for treating glaucoma and/or ocular hypertension |
| 05/03/2007 | WO2007050612A1 2-amino-3,4-dihydro-pyrido[3,4-d]pyrimidine derivatives useful as inhibitors of beta-secretase (bace) |
| 05/03/2007 | WO2007050599A2 Ginkgolides in the treatment and prevention of ovarian cancer |
| 05/03/2007 | WO2007050587A2 Therapeutic compositions and methods |
| 05/03/2007 | WO2007050585A2 Use of a nitric oxide synthase modulator for the treatment of cardiac indications |
| 05/03/2007 | WO2007050574A1 Formulation comprising a drug of low water solubility and method of use thereof |
| 05/03/2007 | WO2007050543A2 Topical pharmaceutical foam composition |
| 05/03/2007 | WO2007050522A1 Derivatives for modulation of ion channels |
| 05/03/2007 | WO2007050513A2 Pseudomonas aeruginosa l-d carboxypeptidase a, expression and activity |
| 05/03/2007 | WO2007050510A2 Hiv integrase inhibitors |
| 05/03/2007 | WO2007050485A2 Combination of a dipeptidyl peptidase-4 inhibitor and an anti-hypertensive agent for the treatment of diabetes and hypertension |
| 05/03/2007 | WO2007050423A2 Skin rejuvinating supplement |
| 05/03/2007 | WO2007050415A2 Poly(ester urea) polymers and methods of use |
| 05/03/2007 | WO2007050405A2 The induction of indoleamine 2,3-dioxygenase in dendritic cells by tlr ligands and uses thereof |
| 05/03/2007 | WO2007050401A2 Tyrosine kinase inhibitors |
| 05/03/2007 | WO2007050383A2 Tyrosine kinase inhibitors |
| 05/03/2007 | WO2007050381A2 3-piperidin-4-yl-indole orl-1 receptor modulators |
| 05/03/2007 | WO2007050380A2 Tyrosine kinase inhibitors |
| 05/03/2007 | WO2007050379A2 Preventing bacterial or viral infectivity and composition containing infection preventing additive |
| 05/03/2007 | WO2007050377A1 Enhanced efficacy benzisoxazole derivative dosage forms and methods |
| 05/03/2007 | WO2007050375A2 Piperazine derivatives useful as ccr5 antagonists |
| 05/03/2007 | WO2007050369A2 Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same |
| 05/03/2007 | WO2007050353A2 Tricyclic compounds useful as oxytocin receptor agonists |
| 05/03/2007 | WO2007050347A1 Potassium channel inhibitors |
| 05/03/2007 | WO2007050294A2 Liquid dosage forms having enteric properties of delayed and then sustained release |
| 05/03/2007 | WO2007050271A2 5-lipoxygenase modulators |
| 05/03/2007 | WO2007050178A2 Skin care composition for accelerated production of collagen proteins and method of fabricating same |
| 05/03/2007 | WO2007050124A1 Fused piperidine derivatives and their uses as therapeutic agents |
| 05/03/2007 | WO2007050087A1 N[S(4-aryl-triazol-3-yl)α -mercaptoacetyl]-p-amino benozoic acids AS HIV REVERSE TRANSCRIPTASE INHIBITORS |
| 05/03/2007 | WO2007050075A1 Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| 05/03/2007 | WO2007050034A1 Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease |
| 05/03/2007 | WO2007049987A1 Method for producing sulphated glycosaminoglycans from a biological tissues |
| 05/03/2007 | WO2007049932A1 Extract of the family dioscoreaceae and composition for preventing or treating peripheral neuropathy comprising the same |
| 05/03/2007 | WO2007049914A1 S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same |
| 05/03/2007 | WO2007049868A1 Stabilized pharmaceutical oral preparation containing clopidogrel bisulfate |
| 05/03/2007 | WO2007049828A1 Therapeutic agent for unstable cerebrospinal pressure syndrome |
| 05/03/2007 | WO2007049825A1 P2x4 receptor antagonist |
| 05/03/2007 | WO2007049820A1 Heterocyclic amide compound and use thereof |
| 05/03/2007 | WO2007049819A1 Therapeutic agent comprising glycolipid derivative capable of inhibiting the function of nkt cell as active ingredient |
| 05/03/2007 | WO2007049818A1 Anti-fatty liver, anti-obesity or hypolipidemic composition |
| 05/03/2007 | WO2007049798A1 Novel benzoxathiin derivative |
| 05/03/2007 | WO2007049796A2 Resveratrol and/or grape leaf extract as i. a. endurance improver, anti-aging agent, muscle strength improver |
| 05/03/2007 | WO2007049786A1 Fat-soluble oil comprising fucoxanthin, process for production of the oil, and process for production of fucoxanthin |
| 05/03/2007 | WO2007049771A1 Compound containing basic group and use thereof |
| 05/03/2007 | WO2007049732A1 Method for prevention and/or treatment of rheumatoid arthritis |
| 05/03/2007 | WO2007049675A1 Polycyclic carbamoylpyridone derivative having inhibitory activity on hiv integrase |
| 05/03/2007 | WO2007049642A1 Regulator of capsaicin receptor activity and pharmaceutical composition using the same |
| 05/03/2007 | WO2007049628A1 Blood flowability-improving agent |
| 05/03/2007 | WO2007049626A1 Oral solid preparation containing cabergoline |
| 05/03/2007 | WO2007049624A1 Preventives/remedies for cancer |
| 05/03/2007 | WO2007049587A1 Enteric-coated preparation |